Edwards Lifesciences outlines TMTT growth target of $500M-$530M for 2025 amid strong Q4 performance
Q4 2024 Management View CEO Bernard Zovighian highlighted a strong Q4 2024 performance with total company sales growing 9% year-over-year to $1.39 billion and adjusted earnings per share of $0.59. He ...
Allison Transmission outlines 2025 guidance with $3.2B-$3.3B revenue target backed by price realization and demand
Q4 2024 Management View CEO David Graziosi highlighted record net sales of $3.2 billion for 2024, attributing growth to strong demand in North America and expansion in defense and other international ...